|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/381 | (2006.01) |
| A61K 31/381 | (2013.01) | ||
| A61K 31/519 | (2006.01) | ||
| A61K 31/519 | (2013.01) | ||
| C07D 487/14 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3565558 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18736115.9 |
| Date of filing the European patent application | 2018-01-05 | |
| (97) | Date of publication of the European application | 2019-11-13 |
| (45) | Date of publication and mention of the grant of the patent | 2023-12-06 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/012675 |
| Date | 2018-01-05 |
| (87) | Number | WO 2018/129387 |
| Date | 2018-07-12 |
| (30) | Number | Date | Country code |
| 201762443588 P | 2017-01-06 | US |
| (72) |
STRUM, Jay, C. , US
THATCHER, Gregory, R. , US
XIONG, Rui , US
ZHAO, Jiong , US
TONETTI, Debra, A. , US
|
| (73) |
G1 Therapeutics, Inc. ,
79 TW Alexander Drive 4501
Research Commons
Suite 100
Research Triangle Park, NC 27709,
US
The Board of Trustees of the University of Illinois , 352 Henry Administration Building 506 South Wright Street, Urbana, IL 61801, US |
| (54) | COMBINATION THERAPY WITH A SERD COMPOUND AND A CDK4/6 INHIBITOR FOR THE TREATMENT OF CANCER |
| COMBINATION THERAPY WITH A SERD COMPOUND AND A CDK4/6 INHIBITOR FOR THE TREATMENT OF CANCER |